Erdheim-Chester Disease; Memorial Sloan Kettering Cancer Center researchers publish landmark 'basket...
Erdheim-Chester Disease; Memorial Sloan Kettering Cancer Center researchers publish landmark 'basket study'
About this item
Full title
Erdheim-Chester Disease; Memorial Sloan Kettering Cancer Center researchers publish landmark 'basket study'
Publisher
Atlanta: NewsRx
Journal title
Obesity, Fitness & Wellness Week, 2015, p.2331
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
Published in the New England Journal of Medicine, the early phase II study, led by MSK Physician-in-Chief and Chief Medical Officer Jose Baselga, MD, PhD, looked at the effect of vemurafenib (Zelboraf(R)) in multiple nonmelanoma BRAFV600-mutated cancers in 122 patients from 23 centers around the world. Vemurafenib previously has been proven to trea...
Alternative Titles
Full title
Erdheim-Chester Disease; Memorial Sloan Kettering Cancer Center researchers publish landmark 'basket study'
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1708950243
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1708950243
Other Identifiers
ISSN
1531-6386
E-ISSN
1532-4664
How to access this item
Log in as a Library member
